Cargando…

Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties

Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marin...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Diaa T. A., Shaala, Lamiaa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693029/
https://www.ncbi.nlm.nih.gov/pubmed/36354986
http://dx.doi.org/10.3390/md20110663
_version_ 1784837432002215936
author Youssef, Diaa T. A.
Shaala, Lamiaa A.
author_facet Youssef, Diaa T. A.
Shaala, Lamiaa A.
author_sort Youssef, Diaa T. A.
collection PubMed
description Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marine-derived psammaplysins possess the rare and unique 1,6-dioxa-2-azaspiro [4.6] undecane backbone and are represented by 44 compounds in the literature, mostly from sponges of the order Verongiida. Compounds with 1,6-dioxa-2-azaspiro [4.6] undecane moiety exist in the literature under five names, including psammaplysins, ceratinamides, frondoplysins, ceratinadins, and psammaceratins. These compounds displayed significant biological properties including growth inhibitory, antimalarial, antifouling, protein tyrosine phosphatase inhibition, antiviral, immunosuppressive, and antioxidant effects. In this review, a comprehensive literature survey covering natural occurrence of the psammaplysins and related compounds, methods of isolation, structural differences, the biogenesis, and biological/pharmacological properties, will be presented.
format Online
Article
Text
id pubmed-9693029
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96930292022-11-26 Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties Youssef, Diaa T. A. Shaala, Lamiaa A. Mar Drugs Review Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marine-derived psammaplysins possess the rare and unique 1,6-dioxa-2-azaspiro [4.6] undecane backbone and are represented by 44 compounds in the literature, mostly from sponges of the order Verongiida. Compounds with 1,6-dioxa-2-azaspiro [4.6] undecane moiety exist in the literature under five names, including psammaplysins, ceratinamides, frondoplysins, ceratinadins, and psammaceratins. These compounds displayed significant biological properties including growth inhibitory, antimalarial, antifouling, protein tyrosine phosphatase inhibition, antiviral, immunosuppressive, and antioxidant effects. In this review, a comprehensive literature survey covering natural occurrence of the psammaplysins and related compounds, methods of isolation, structural differences, the biogenesis, and biological/pharmacological properties, will be presented. MDPI 2022-10-25 /pmc/articles/PMC9693029/ /pubmed/36354986 http://dx.doi.org/10.3390/md20110663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Youssef, Diaa T. A.
Shaala, Lamiaa A.
Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
title Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
title_full Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
title_fullStr Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
title_full_unstemmed Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
title_short Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
title_sort psammaplysins: insights from natural sources, structural variations, and pharmacological properties
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693029/
https://www.ncbi.nlm.nih.gov/pubmed/36354986
http://dx.doi.org/10.3390/md20110663
work_keys_str_mv AT youssefdiaata psammaplysinsinsightsfromnaturalsourcesstructuralvariationsandpharmacologicalproperties
AT shaalalamiaaa psammaplysinsinsightsfromnaturalsourcesstructuralvariationsandpharmacologicalproperties